These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

635 related articles for article (PubMed ID: 16299289)

  • 21. Toll like receptor agonists augment HPV 11 E7-specific T cell responses by modulating monocyte-derived dendritic cells.
    Chen XZ; Mao XH; Zhu KJ; Jin N; Ye J; Cen JP; Zhou Q; Cheng H
    Arch Dermatol Res; 2010 Jan; 302(1):57-65. PubMed ID: 19578865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NOD-like receptors and RIG-I-like receptors in human eosinophils: activation by NOD1 and NOD2 agonists.
    Kvarnhammar AM; Petterson T; Cardell LO
    Immunology; 2011 Nov; 134(3):314-25. PubMed ID: 21978001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancement of endotoxin activity by muramyldipeptide.
    Takada H; Yokoyama S; Yang S
    J Endotoxin Res; 2002; 8(5):337-42. PubMed ID: 12537692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A vitamin D3 analog augmented interleukin-8 production by human monocytic cells in response to various microbe-related synthetic ligands, especially NOD2 agonistic muramyldipeptide.
    Ikeuchi T; Nakamura T; Fukumoto S; Takada H
    Int Immunopharmacol; 2013 Jan; 15(1):15-22. PubMed ID: 23159604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12.
    Krug A; Towarowski A; Britsch S; Rothenfusser S; Hornung V; Bals R; Giese T; Engelmann H; Endres S; Krieg AM; Hartmann G
    Eur J Immunol; 2001 Oct; 31(10):3026-37. PubMed ID: 11592079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The frameshift mutation in Nod2 results in unresponsiveness not only to Nod2- but also Nod1-activating peptidoglycan agonists.
    Netea MG; Ferwerda G; de Jong DJ; Werts C; Boneca IG; Jéhanno M; Van Der Meer JW; Mengin-Lecreulx D; Sansonetti PJ; Philpott DJ; Dharancy S; Girardin SE
    J Biol Chem; 2005 Oct; 280(43):35859-67. PubMed ID: 16115863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of CD40 ligation and interferon-gamma on functional properties of human monocyte-derived dendritic cells activated with polyinosinic-polycytidylic acid.
    Dragicević A; Dzopalić T; Vasilijić S; Vucević D; Bozić B; Majstorović I; Balint B; Colić M
    Vojnosanit Pregl; 2011 Apr; 68(4):301-8. PubMed ID: 21627015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Powerful Complex Immunoadjuvant Based on Synergistic Effect of Combined TLR4 and NOD2 Activation Significantly Enhances Magnitude of Humoral and Cellular Adaptive Immune Responses.
    Tukhvatulin AI; Dzharullaeva AS; Tukhvatulina NM; Shcheblyakov DV; Shmarov MM; Dolzhikova IV; Stanhope-Baker P; Naroditsky BS; Gudkov AV; Logunov DY; Gintsburg AL
    PLoS One; 2016; 11(5):e0155650. PubMed ID: 27187797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Muramyl dipeptide enhances osteoclast formation induced by lipopolysaccharide, IL-1 alpha, and TNF-alpha through nucleotide-binding oligomerization domain 2-mediated signaling in osteoblasts.
    Yang S; Takahashi N; Yamashita T; Sato N; Takahashi M; Mogi M; Uematsu T; Kobayashi Y; Nakamichi Y; Takeda K; Akira S; Takada H; Udagawa N; Furusawa K
    J Immunol; 2005 Aug; 175(3):1956-64. PubMed ID: 16034140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism.
    Netea MG; Azam T; Ferwerda G; Girardin SE; Walsh M; Park JS; Abraham E; Kim JM; Yoon DY; Dinarello CA; Kim SH
    Proc Natl Acad Sci U S A; 2005 Nov; 102(45):16309-14. PubMed ID: 16260731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergistic effect of muramyldipeptide with lipopolysaccharide or lipoteichoic acid to induce inflammatory cytokines in human monocytic cells in culture.
    Yang S; Tamai R; Akashi S; Takeuchi O; Akira S; Sugawara S; Takada H
    Infect Immun; 2001 Apr; 69(4):2045-53. PubMed ID: 11254557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibodies to proteinase 3 prime human monocytic cells via protease-activated receptor-2 and NF-kappaB for Toll-like receptor- and NOD-dependent activation.
    Uehara A; Iwashiro A; Sato T; Yokota S; Takada H
    Mol Immunol; 2007 Jul; 44(14):3552-62. PubMed ID: 17452051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nucleotide-binding oligomerization domain-2 modulates specific TLR pathways for the induction of cytokine release.
    Netea MG; Ferwerda G; de Jong DJ; Jansen T; Jacobs L; Kramer M; Naber TH; Drenth JP; Girardin SE; Kullberg BJ; Adema GJ; Van der Meer JW
    J Immunol; 2005 May; 174(10):6518-23. PubMed ID: 15879155
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined CpG and poly I:C stimulation of monocytes results in unique signaling activation not observed with the individual ligands.
    Arsenault RJ; Kogut MH; He H
    Cell Signal; 2013 Nov; 25(11):2246-54. PubMed ID: 23876795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergy between TLR9 and NOD2 innate immune responses is lost in genetic Crohn's disease.
    van Heel DA; Ghosh S; Hunt KA; Mathew CG; Forbes A; Jewell DP; Playford RJ
    Gut; 2005 Nov; 54(11):1553-7. PubMed ID: 15928043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NOD2 ligation subverts IFN-alpha production by liver plasmacytoid dendritic cells and inhibits their T cell allostimulatory activity via B7-H1 up-regulation.
    Castellaneta A; Sumpter TL; Chen L; Tokita D; Thomson AW
    J Immunol; 2009 Dec; 183(11):6922-32. PubMed ID: 19890047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TLR8 and NOD signaling synergistically induce the production of IL-1β and IL-23 in monocyte-derived DCs and enhance the expression of the feedback inhibitor SOCS2.
    Schwarz H; Posselt G; Wurm P; Ulbing M; Duschl A; Horejs-Hoeck J
    Immunobiology; 2013 Apr; 218(4):533-42. PubMed ID: 22795647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Meso-diaminopimelic acid and meso-lanthionine, amino acids specific to bacterial peptidoglycans, activate human epithelial cells through NOD1.
    Uehara A; Fujimoto Y; Kawasaki A; Kusumoto S; Fukase K; Takada H
    J Immunol; 2006 Aug; 177(3):1796-804. PubMed ID: 16849490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells.
    Napolitani G; Rinaldi A; Bertoni F; Sallusto F; Lanzavecchia A
    Nat Immunol; 2005 Aug; 6(8):769-76. PubMed ID: 15995707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TLR agonist combinations that stimulate Th type I polarizing responses from human neonates.
    Surendran N; Simmons A; Pichichero ME
    Innate Immun; 2018 May; 24(4):240-251. PubMed ID: 29673285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.